Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural Networks.


Journal

JAMA dermatology
ISSN: 2168-6084
Titre abrégé: JAMA Dermatol
Pays: United States
ID NLM: 101589530

Informations de publication

Date de publication:
01 01 2019
Historique:
pubmed: 30 11 2018
medline: 15 10 2019
entrez: 29 11 2018
Statut: ppublish

Résumé

Convolutional neural networks (CNNs) achieve expert-level accuracy in the diagnosis of pigmented melanocytic lesions. However, the most common types of skin cancer are nonpigmented and nonmelanocytic, and are more difficult to diagnose. To compare the accuracy of a CNN-based classifier with that of physicians with different levels of experience. A CNN-based classification model was trained on 7895 dermoscopic and 5829 close-up images of lesions excised at a primary skin cancer clinic between January 1, 2008, and July 13, 2017, for a combined evaluation of both imaging methods. The combined CNN (cCNN) was tested on a set of 2072 unknown cases and compared with results from 95 human raters who were medical personnel, including 62 board-certified dermatologists, with different experience in dermoscopy. The proportions of correct specific diagnoses and the accuracy to differentiate between benign and malignant lesions measured as an area under the receiver operating characteristic curve served as main outcome measures. Among 95 human raters (51.6% female; mean age, 43.4 years; 95% CI, 41.0-45.7 years), the participants were divided into 3 groups (according to years of experience with dermoscopy): beginner raters (<3 years), intermediate raters (3-10 years), or expert raters (>10 years). The area under the receiver operating characteristic curve of the trained cCNN was higher than human ratings (0.742; 95% CI, 0.729-0.755 vs 0.695; 95% CI, 0.676-0.713; P < .001). The specificity was fixed at the mean level of human raters (51.3%), and therefore the sensitivity of the cCNN (80.5%; 95% CI, 79.0%-82.1%) was higher than that of human raters (77.6%; 95% CI, 74.7%-80.5%). The cCNN achieved a higher percentage of correct specific diagnoses compared with human raters (37.6%; 95% CI, 36.6%-38.4% vs 33.5%; 95% CI, 31.5%-35.6%; P = .001) but not compared with experts (37.3%; 95% CI, 35.7%-38.8% vs 40.0%; 95% CI, 37.0%-43.0%; P = .18). Neural networks are able to classify dermoscopic and close-up images of nonpigmented lesions as accurately as human experts in an experimental setting.

Identifiants

pubmed: 30484822
pii: 2716294
doi: 10.1001/jamadermatol.2018.4378
pmc: PMC6439580
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

58-65

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Br J Dermatol. 2011 Apr;164(4):797-806
pubmed: 21294715
Arch Dermatol. 2005 Nov;141(11):1388-96
pubmed: 16301386
Cancer Res. 2012 May 15;72(10):2491-500
pubmed: 22434431
Exp Dermatol. 2018 Nov;27(11):1261-1267
pubmed: 30187575
Nature. 2017 Feb 2;542(7639):115-118
pubmed: 28117445
JAMA. 2018 Jun 12;319(22):2267-2268
pubmed: 29800012
PLoS One. 2018 Mar 7;13(3):e0193321
pubmed: 29513718
Australas J Dermatol. 2011 Feb;52(1):76-8
pubmed: 21332701
Br J Dermatol. 2014 Nov;171(5):1099-107
pubmed: 24841846
J Am Acad Dermatol. 2017 Dec;77(6):1100-1109
pubmed: 28941871
JAMA Dermatol. 2017 May 1;153(5):453-457
pubmed: 28241182
J Am Acad Dermatol. 2018 Feb;78(2):270-277.e1
pubmed: 28969863
AMIA Annu Symp Proc. 2007 Oct 11;:191-5
pubmed: 18693824
Arch Dermatol. 2008 Sep;144(9):1120-7
pubmed: 18794455
Melanoma Res. 2000 Dec;10(6):556-61
pubmed: 11198477
J Am Acad Dermatol. 2012 Jul;67(1):54-9
pubmed: 21982636
J Am Acad Dermatol. 2016 Jun;74(6):1093-106
pubmed: 26896294
IEEE J Biomed Health Inform. 2018 Apr 09;:
pubmed: 29993994
Skin Res Technol. 2018 May;24(2):256-264
pubmed: 29057507
Int J Cancer. 2002 Oct 20;101(6):576-80
pubmed: 12237900
Br J Dermatol. 2017 Sep;177(3):867-869
pubmed: 28569993
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Br J Dermatol. 1994 Apr;130(4):460-5
pubmed: 8186110
J Invest Dermatol. 2018 Jul;138(7):1529-1538
pubmed: 29428356
Ann Oncol. 2018 Aug 1;29(8):1836-1842
pubmed: 29846502
J Am Acad Dermatol. 2011 Jun;64(6):1068-73
pubmed: 21440329
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
J Am Acad Dermatol. 2004 May;50(5):683-9
pubmed: 15097950

Auteurs

Philipp Tschandl (P)

School of Computing Science, Simon Fraser University, Burnaby, British Columbia, Canada.
Vienna Dermatologic Imaging Research Group, Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Cliff Rosendahl (C)

School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Bengu Nisa Akay (BN)

Department of Dermatology, Ankara University Faculty of Medicine, Ankara, Turkey.

Giuseppe Argenziano (G)

Dermatology Unit, University of Campania, Naples, Italy.

Andreas Blum (A)

Public, Private and Teaching Practice of Dermatology, Konstanz, Germany.

Ralph P Braun (RP)

Department of Dermatology, University Hospital Zürich, Zürich, Switzerland.

Horacio Cabo (H)

Department of Dermatology, Instituto de Investigaciones Médicas ALanari, University of Buenos Aires, Buenos Aires, Argentina.

Jean-Yves Gourhant (JY)

Centre de Dermatologie, Nemours, France.

Jürgen Kreusch (J)

private practice, Lübeck, Germany.

Aimilios Lallas (A)

First Department of Dermatology, Aristotle University, Thessaloniki, Greece.

Jan Lapins (J)

Department of Dermatology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.

Ashfaq Marghoob (A)

Dermatology Service, Memorial Sloan Kettering Cancer Center, Hauppauge, New York.

Scott Menzies (S)

Sydney Melanoma Diagnostic Centre and Discipline of Dermatology, University of Sydney, Sydney, Australia.

Nina Maria Neuber (NM)

Vienna Dermatologic Imaging Research Group, Department of Dermatology, Medical University of Vienna, Vienna, Austria.

John Paoli (J)

Department of Dermatology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Harold S Rabinovitz (HS)

Skin and Cancer Associates, Plantation, Florida.

Christoph Rinner (C)

Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

Alon Scope (A)

Medical Screening Institute, Chaim Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

H Peter Soyer (HP)

Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Brisbane, Australia.

Christoph Sinz (C)

Vienna Dermatologic Imaging Research Group, Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Luc Thomas (L)

Department of Dermatology, Centre Hospitalier Lyon Sud, Lyon 1 University, Lyons Cancer Research Center, Lyon, France.

Iris Zalaudek (I)

Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy.

Harald Kittler (H)

Vienna Dermatologic Imaging Research Group, Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH